DGX — Quest Diagnostics Incorporated
$259.60
$-0.05 (-0.02%)
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Market Cap
$28.56B
Forward P/E
21.7x
52-Week Range
N/A
DGX Price History
Revenue vs. Net Income
$11B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$1.4B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
11.4%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.8x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
4.8%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+0.0%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
